메뉴 건너뛰기




Volumn 55, Issue 5, 2012, Pages 700-709

Using value of information analysis in decision making about applied research. The case of genetic screening for hemochromatosis in Germany;Die nutzung von informationswertanalysen in entscheidungen über angewandte forschung: Der fall des genetischen screenings auf hämochromatose in Deutschland

Author keywords

Adherence; Cost effectiveness; Hereditary hemochromatosis; Translational research; Value of information

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; GENETIC SCREENING; GENETICS; GERMANY; HEALTH CARE COST; HEMOCHROMATOSIS; HUMAN; INFORMATION RETRIEVAL; MALE; PREVALENCE; STATISTICS; TRANSLATIONAL RESEARCH;

EID: 84863886257     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-012-1474-7     Document Type: Article
Times cited : (5)

References (37)
  • 1
    • 55249092701 scopus 로고    scopus 로고
    • Genomics research: World survey of public funding
    • Pohlhaus JR, Cook-Deegan RM (2008) Genomics research: world survey of public funding. BMC Genomics 9:472
    • (2008) BMC Genomics , vol.9 , pp. 472
    • Pohlhaus, J.R.1    Cook-Deegan, R.M.2
  • 2
    • 67649732906 scopus 로고    scopus 로고
    • Challenges of translating genetic tests into clinical and public health practice
    • Rogowski WH, Grosse SD, Khoury MJ (2009) Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet 10:489-495
    • (2009) Nat Rev Genet , vol.10 , pp. 489-495
    • Rogowski, W.H.1    Grosse, S.D.2    Khoury, M.J.3
  • 3
    • 26444505936 scopus 로고    scopus 로고
    • Translational and clinical science - Time for a new vision
    • DOI 10.1056/NEJMsb053723
    • Zerhouni EA (2005) Translational and clinical science-time for a new vision. N Engl J Med 353:1621-1623 (Pubitemid 41434645)
    • (2005) New England Journal of Medicine , vol.353 , Issue.15 , pp. 1621-1623
    • Zerhouni, E.A.1
  • 4
    • 37349116252 scopus 로고    scopus 로고
    • The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
    • DOI 10.1097/GIM.0b013e31815699d0, PII 0012581720071000000001
    • Khoury MJ, Gwinn M, Yoon PW et al (2007) The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 9:665-674 (Pubitemid 350287151)
    • (2007) Genetics in Medicine , vol.9 , Issue.10 , pp. 665-674
    • Khoury, M.J.1    Gwinn, M.2    Yoon, P.W.3    Dowling, N.4    Moore, C.A.5    Bradley, L.6
  • 5
    • 70649084197 scopus 로고    scopus 로고
    • Entscheidungsanalytische Modellierung von Kosten pro QALY im Kontext des deutschen Sozialrechts
    • Rogowski WH, Landauer M, John J (2009) Entscheidungsanalytische Modellierung von Kosten pro QALY im Kontext des deutschen Sozialrechts. Gesundheitswesen 71:739-750
    • (2009) Gesundheitswesen , vol.71 , pp. 739-750
    • Rogowski, W.H.1    Landauer, M.2    John, J.3
  • 6
    • 44649149706 scopus 로고    scopus 로고
    • Does health care spending improve health outcomes? Evidence from English programme budgeting data
    • Martin S, Rice N, Smith PC (2008) Does health care spending improve health outcomes? Evidence from English programme budgeting data. J Health Econ 27:826-842
    • (2008) J Health Econ , vol.27 , pp. 826-842
    • Martin, S.1    Rice, N.2    Smith, P.C.3
  • 7
    • 0033044884 scopus 로고    scopus 로고
    • The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies
    • DOI 10.1016/S0167-6296(98)00039-3, PII S0167629698000393
    • Claxton K (1999) The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18:341-364 (Pubitemid 29242816)
    • (1999) Journal of Health Economics , vol.18 , Issue.3 , pp. 341-364
    • Claxton, K.1
  • 8
    • 33750600068 scopus 로고    scopus 로고
    • Using value of information analysis to prioritise health research: Some lessons from recent UK experience
    • Claxton KP, Sculpher MJ (2006) Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmaco Econ 24:1055-1068 (Pubitemid 44683363)
    • (2006) PharmacoEconomics , vol.24 , Issue.11 , pp. 1055-1068
    • Claxton, K.P.1    Sculpher, M.J.2
  • 9
    • 33845662699 scopus 로고    scopus 로고
    • Informing the efficient use of health care and health care research resources - The case of screening for abdominal aortic aneurysm in Sweden
    • DOI 10.1002/hec.1130
    • Henriksson M, Lundgren F, Carlsson P (2006) Informing the efficient use of health care and health care research resources - the case of screening for abdominal aortic aneurysm in Sweden. Health Econ 15:1311-1322 (Pubitemid 44941607)
    • (2006) Health Economics , vol.15 , Issue.12 , pp. 1311-1322
    • Henriksson, M.1    Lundgren, F.2    Carlsson, P.3
  • 10
    • 4444284468 scopus 로고    scopus 로고
    • A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme
    • iii
    • Claxton K, Ginnelly L, Sculpher M et al (2004) A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess 8:1-103, iii
    • (2004) Health Technol Assess , vol.8 , pp. 1-103
    • Claxton, K.1    Ginnelly, L.2    Sculpher, M.3
  • 12
    • 64549148979 scopus 로고    scopus 로고
    • The cost-effectiveness of screening for hereditary hemochromatosis in Germany: A remodeling study
    • Rogowski WH (2009) The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study. Med Decis Making 29:224-238
    • (2009) Med Decis Making , vol.29 , pp. 224-238
    • Rogowski, W.H.1
  • 13
    • 33746830877 scopus 로고    scopus 로고
    • Screening for hereditary hemochromatosis: A systematic review for the U.S. preventive services task force
    • Whitlock EP, Garlitz BA, Harris EL et al (2006) Screening for hereditary hemochromatosis: a systematic review for the U. S. preventive services task force. Ann Intern Med 145:209-223 (Pubitemid 46780566)
    • (2006) Annals of Internal Medicine , vol.145 , Issue.3 , pp. 209-223
    • Whitlock, E.P.1    Garlitz, B.A.2    Harris, E.L.3    Beil, T.L.4    Smith, P.R.5
  • 14
    • 25444500981 scopus 로고    scopus 로고
    • Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians
    • Schmitt B, Golub RM, Green R (2005) Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med 143:522-536
    • (2005) Ann Intern Med , vol.143 , pp. 522-536
    • Schmitt, B.1    Golub, R.M.2    Green, R.3
  • 15
    • 72849151855 scopus 로고    scopus 로고
    • Population screening for genetic disorders in the 21st century: Evidence, economics, and ethics
    • Grosse SD, Rogowski WH, Ross LF et al (2010) Population screening for genetic disorders in the 21st century: evidence, economics, and ethics. Public Health Genomics 13:106-115
    • (2010) Public Health Genomics , vol.13 , pp. 106-115
    • Grosse, S.D.1    Rogowski, W.H.2    Ross, L.F.3
  • 16
    • 36549053552 scopus 로고    scopus 로고
    • Haemochromatosis
    • DOI 10.1016/S0140-6736(07)61782-6, PII S0140673607617826
    • Adams PC, Barton JC (2007) Haemochromatosis. Lancet 370:1855-1860 (Pubitemid 350180034)
    • (2007) Lancet , vol.370 , Issue.9602 , pp. 1855-1860
    • Adams, P.C.1    Barton, J.C.2
  • 17
    • 33845545966 scopus 로고    scopus 로고
    • Hereditary hemochromatosis screening: Effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms
    • DOI 10.1111/j.1399-0004.2006.00727.x
    • Gagne G, Reinharz D, Laflamme N et al (2007) Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on costeffectiveness of testing algorithms. Clin Genet 71:46-58 (Pubitemid 44921621)
    • (2007) Clinical Genetics , vol.71 , Issue.1 , pp. 46-58
    • Gagne, G.1    Reinharz, D.2    Laflamme, N.3    Adams, P.C.4    Rousseau, F.5
  • 18
    • 33750583986 scopus 로고    scopus 로고
    • Leitlinie zur molekulargenetischen Diagnostikder hereditären Hämochromatose
    • Gabriel H, Stuhrmann M (2006) Leitlinie zur molekulargenetischen Diagnostikder hereditären Hämochromatose. Med Genet 18:273-278
    • (2006) Med Genet , vol.18 , pp. 273-278
    • Gabriel, H.1    Stuhrmann, M.2
  • 19
    • 12744260147 scopus 로고    scopus 로고
    • Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study
    • Stuhrmann M, Strassburg C, Schmidtke J (2005) Genotype-based screening for hereditary haemochromatosis. I: technical performance, costs and clinical relevance of a German pilot study. Eur J Hum Genet 13:69-78
    • (2005) Eur J Hum Genet , vol.13 , pp. 69-78
    • Stuhrmann, M.1    Strassburg, C.2    Schmidtke, J.3
  • 20
    • 0036793757 scopus 로고    scopus 로고
    • Benefit of population-based screening for phenotypic hemochromatosis in young men
    • DOI 10.1080/003655202760373443
    • Asberg A, Tretli S, Hveem K, Bjerve KS (2002) Benefit of population-based screening for phenotypic hemochromatosis in young men. Scand J Gastroenterol 37:1212-1219 (Pubitemid 35178688)
    • (2002) Scandinavian Journal of Gastroenterology , vol.37 , Issue.10 , pp. 1212-1219
    • Asberg, A.1    Tretli, S.2    Hveem, K.3    Bjerve, K.S.4
  • 22
    • 1442282237 scopus 로고    scopus 로고
    • Evolution of Untreated Hereditary Hemochromatosis in the Busselton Population: A 17-Year Study
    • Olynyk JK, Hagan SE, Cullen DJ et al (2004) Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc 79:309-313 (Pubitemid 38269232)
    • (2004) Mayo Clinic Proceedings , vol.79 , Issue.3 , pp. 309-313
    • Olynyk, J.K.1    Hagan, S.E.2    Cullen, D.J.3    Beilby, J.4    Whittall, D.E.5
  • 24
    • 0141794515 scopus 로고    scopus 로고
    • Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis
    • DOI 10.1111/j.1572-0241.2003.07292.x
    • Hicken BL, Tucker DC, Barton JC (2003) Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Am J Gastroenterol 98:2072-2077 (Pubitemid 37185808)
    • (2003) American Journal of Gastroenterology , vol.98 , Issue.9 , pp. 2072-2077
    • Hicken, B.L.1    Tucker, D.C.2    Barton, J.C.3
  • 26
    • 44049098205 scopus 로고    scopus 로고
    • The half-life of truth: What are appropriate time horizons for research decisions?
    • DOI 10.1177/0272989X07312724
    • Philips Z, Claxton K, Palmer S (2008) The half-life of the truth. Appropriate time horizons for research decisions? Med Decis Making 28(3):287-299 (Pubitemid 351713302)
    • (2008) Medical Decision Making , vol.28 , Issue.3 , pp. 287-299
    • Philips, Z.1    Claxton, K.2    Palmer, S.3
  • 27
    • 2442717630 scopus 로고    scopus 로고
    • Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
    • DOI 10.1002/hec.864
    • Devlin N, Parkin D (2004) Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 13:437-452 (Pubitemid 38660393)
    • (2004) Health Economics , vol.13 , Issue.5 , pp. 437-452
    • Devlin, N.1    Parkin, D.2
  • 29
    • 0010178771 scopus 로고    scopus 로고
    • Are pharmaceuticals cost-effective? A review of the evidence
    • Neumann PJ, Sandberg EA, Bell CM et al (2000) Are pharmaceuticals cost-effective? A review of the evidence. Health Aff (Millwood) 19:92-109
    • (2000) Health Aff (Millwood) , vol.19 , pp. 92-109
    • Neumann, P.J.1    Sandberg, E.A.2    Bell, C.M.3
  • 30
    • 41149171625 scopus 로고    scopus 로고
    • What does the value of modern medicine say about the $50, 000 per quality-adjusted life-year decision rule?
    • Braithwaite RS, Meltzer DO, King JT Jr et al (2008) What does the value of modern medicine say about the $50, 000 per quality-adjusted life-year decision rule? Med Care 46:349-356
    • (2008) Med Care , vol.46 , pp. 349-356
    • Braithwaite, R.S.1    Meltzer, D.O.2    King Jr., J.T.3
  • 31
    • 46949100710 scopus 로고    scopus 로고
    • Assessing cost-effectiveness in healthcare: History of the $50,000 per QALY threshold
    • DOI 10.1586/14737167.8.2.165
    • Grosse SD (2008) Assessing cost-effectiveness in healthcare: history of the $50, 000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 8:165-178 (Pubitemid 351959547)
    • (2008) Expert Review of Pharmacoeconomics and Outcomes Research , vol.8 , Issue.2 , pp. 165-178
    • Grosse, S.D.1
  • 32
    • 41149134764 scopus 로고    scopus 로고
    • How much areamericans willing to pay for a quality-adjusted life year?
    • Weinstein MC (2008) How much areamericans willing to pay for a quality-adjusted life year? Med Care 46:343-345
    • (2008) Med Care , vol.46 , pp. 343-345
    • Weinstein, M.C.1
  • 33
    • 77951080958 scopus 로고    scopus 로고
    • The efficiency frontier approach to economic evaluation of health-care interventions
    • Caro JJ, Nord E, Siebert U et al (2010) The efficiency frontier approach to economic evaluation of health-care interventions. Health Econ 19:1117-1127
    • (2010) Health Econ , vol.19 , pp. 1117-1127
    • Caro, J.J.1    Nord, E.2    Siebert, U.3
  • 34
    • 77957332188 scopus 로고    scopus 로고
    • Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods
    • Sculpher M, Claxton K (2010) Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods. Health Econ 19:1132-1136
    • (2010) Health Econ , vol.19 , pp. 1132-1136
    • Sculpher, M.1    Claxton, K.2
  • 36
    • 77952886612 scopus 로고    scopus 로고
    • Cost-effectiveness of patient mailings to promote colorectal cancer screening
    • Sequist TD, Franz C, Ayanian JZ (2010) Cost-effectiveness of patient mailings to promote colorectal cancer screening. Med Care 48:553-557
    • (2010) Med Care , vol.48 , pp. 553-557
    • Sequist, T.D.1    Franz, C.2    Ayanian, J.Z.3
  • 37
    • 3042677239 scopus 로고    scopus 로고
    • Cost-effectiveness of an intervention to increase cancer screening in primary care settings
    • DOI 10.1016/j.ypmed.2004.03.021, PII S009174350400180X
    • Chirikos TN, Christman LK, Hunter S, Roetzheim RG (2004) Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev Med 39:230-238 (Pubitemid 38834012)
    • (2004) Preventive Medicine , vol.39 , Issue.2 , pp. 230-238
    • Chirikos, T.N.1    Christman, L.K.2    Hunter, S.3    Roetzheim, R.G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.